All calculators
Cardiovascular
Framingham 10-Year CVD Risk
Estimate 10-year cardiovascular disease risk using the simplified Framingham points-based model.
When to use: Use the Framingham Risk Score to estimate 10-year atherosclerotic CVD risk in asymptomatic adults aged 20–79 without pre-existing CVD. It informs decisions on statin therapy initiation (intermediate-to-high risk), aspirin use, and lifestyle intervention intensity. Indian patients have higher CVD risk at lower Framingham scores — consider applying a South Asian risk multiplier (×1.5–2).
Calculator
Adds 1 additional point for treated hypertension at any SBP tier
Fill in all fields to see the result
Formula
Points = Age pts + Total Cholesterol pts + HDL pts + SBP pts (±1 if treated) + Smoking(+4) + Diabetes(+4)
≤9pts→<1% | 10→1% | 11→3% | 12→5% | 13→8% | 14→12% | 15→17% | 16→22% | 17→27% | ≥18→≥30%
Risk categories: <10% Low, 10–20% Intermediate, ≥20% High
Key Points for NEET PG
- Framingham Heart Study: the landmark ongoing US cohort study from 1948 that identified major CVD risk factors.
- Three risk tiers: <10% (low), 10–20% (intermediate), >20% (high) — statin indicated at ≥10% 10-year risk per ACC/AHA 2019.
- HDL is cardioprotective — higher HDL reduces Framingham score; HDL ≥60 mg/dL is a negative risk factor.
- Indian patients: diabetes, central obesity, insulin resistance lead to CVD at younger age and lower LDL compared to Western populations.
- ACC/AHA 2013 Pooled Cohort Equations (PCE) have largely replaced Framingham for clinical use in the US, but Framingham is still tested in Indian PG exams.
References
Wilson PW et al. Prediction of coronary heart disease using risk factor categories · Circulation (1998)
Grundy SM et al. 2018 AHA/ACC Guideline on the Management of Blood Cholesterol · J Am Coll Cardiol (2019)
For educational purposes only. Not for clinical decision-making without professional oversight.